Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers

Published:2016-06-05 Issue:8 Volume:111 Page:1477-1487
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Fitzgerald Niamh¹,Angus Kathryn¹^ORCID,Elders Andrew²,Andrade Marisa³,Raistrick Duncan⁴,Heather Nick⁵,McCambridge Jim⁶

Affiliation:

1. Institute for Social Marketing, UK Centre for Tobacco Alcohol Studies University of Stirling Scotland UK

2. Glasgow Caledonian University Glasgow Scotland UK

3. School of Health in Social Science University of Edinburgh Edinburgh Scotland UK

4. Leeds Addiction Unit Leeds UK

5. Department of Psychology, Faculty of Health and Life Sciences Northumbria University Newcastle upon Tyne UK

6. Department of Health Sciences University of York York UK

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.13438

Reference89 articles.

1. Clinical trials: what a waste

2. Promoting Transparency in Pharmaceutical Industry–Sponsored Research

3. Transparency and the European Medicines Agency — Sharing of Clinical Trial Data

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A critical scientific evaluation of a purportedly negative data report – response to Seneviratne et al. 2022;Frontiers in Psychiatry;2023-10-04

2. The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder;Expert Opinion on Pharmacotherapy;2022-06-03

3. Alcohol Use Disorder: Neurobiology and Therapeutics;Biomedicines;2022-05-21

4. Clinical moderators of response to nalmefene in a randomized-controlled trial for alcohol dependence: An exploratory analysis;Drug and Alcohol Dependence;2022-04

5. Randomized Controlled Trials and the Efficacy of Psychotropic Medications;NeuroPsychopharmacotherapy;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3